These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

571 related items for PubMed ID: 19327900

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Concurrent chemoradiotherapy for esophageal cancer with malignant fistula.
    Koike R, Nishimura Y, Nakamatsu K, Kanamori S, Shibata T.
    Int J Radiat Oncol Biol Phys; 2008 Apr 01; 70(5):1418-22. PubMed ID: 18234437
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Phase II study of chemoradiotherapy with 5-fluorouracil and cisplatin for Stage II-III esophageal squamous cell carcinoma: JCOG trial (JCOG 9906).
    Kato K, Muro K, Minashi K, Ohtsu A, Ishikura S, Boku N, Takiuchi H, Komatsu Y, Miyata Y, Fukuda H, Gastrointestinal Oncology Study Group of the Japan Clinical Oncology Group (JCOG).
    Int J Radiat Oncol Biol Phys; 2011 Nov 01; 81(3):684-90. PubMed ID: 20932658
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of concurrent chemoradiotherapy as a palliative treatment in stage IVB esophageal cancer patients with dysphagia.
    Ikeda E, Kojima T, Kaneko K, Minashi K, Onozawa M, Nihei K, Fuse N, Yano T, Yoshino T, Tahara M, Doi T, Ohtsu A.
    Jpn J Clin Oncol; 2011 Aug 01; 41(8):964-72. PubMed ID: 21742654
    [Abstract] [Full Text] [Related]

  • 11. Dose-response relationship in locoregional control for patients with stage II-III esophageal cancer treated with concurrent chemotherapy and radiotherapy.
    Zhang Z, Liao Z, Jin J, Ajani J, Chang JY, Jeter M, Guerrero T, Stevens CW, Swisher S, Ho L, Yao J, Allen P, Cox JD, Komaki R.
    Int J Radiat Oncol Biol Phys; 2005 Mar 01; 61(3):656-64. PubMed ID: 15708243
    [Abstract] [Full Text] [Related]

  • 12. Radiotherapy with or without concurrent chemotherapy for lymph node recurrence after radical surgery of thoracic esophageal squamous cell carcinoma.
    Lu JC, Kong C, Tao H.
    Int J Radiat Oncol Biol Phys; 2010 Nov 01; 78(3):710-4. PubMed ID: 20172661
    [Abstract] [Full Text] [Related]

  • 13. Late course accelerated hyperfractionated radiotherapy plus concurrent chemotherapy for squamous cell carcinoma of the esophagus: a phase III randomized study.
    Zhao KL, Shi XH, Jiang GL, Yao WQ, Guo XM, Wu GD, Zhu LX.
    Int J Radiat Oncol Biol Phys; 2005 Jul 15; 62(4):1014-20. PubMed ID: 15990003
    [Abstract] [Full Text] [Related]

  • 14. Clinical results of definitive chemoradiotherapy for patients with synchronous head and neck squamous cell carcinoma and esophageal cancer.
    Shinoto M, Shioyama Y, Sasaki T, Nakamura K, Ohura H, Toh Y, Higaki Y, Yamaguchi T, Ohnishi K, Atsumi K, Hirata H, Honda H.
    Am J Clin Oncol; 2011 Aug 15; 34(4):362-6. PubMed ID: 20686402
    [Abstract] [Full Text] [Related]

  • 15. Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience.
    Salama JK, Mell LK, Schomas DA, Miller RC, Devisetty K, Jani AB, Mundt AJ, Roeske JC, Liauw SL, Chmura SJ.
    J Clin Oncol; 2007 Oct 10; 25(29):4581-6. PubMed ID: 17925552
    [Abstract] [Full Text] [Related]

  • 16. Myelotoxicity of preoperative chemoradiotherapy is a significant determinant of poor prognosis in patients with T4 esophageal cancer.
    Miyoshi N, Yano M, Takachi K, Kishi K, Noura S, Eguchi H, Yamada T, Miyashiro I, Ohue M, Ohigashi H, Sasaki Y, Ishikawa O, Doki Y, Imaoka S.
    J Surg Oncol; 2009 Apr 01; 99(5):302-6. PubMed ID: 19170110
    [Abstract] [Full Text] [Related]

  • 17. Prospective comparison of surgery alone and chemoradiotherapy with selective surgery in resectable squamous cell carcinoma of the esophagus.
    Ariga H, Nemoto K, Miyazaki S, Yoshioka T, Ogawa Y, Sakayauchi T, Jingu K, Miyata G, Onodera K, Ichikawa H, Kamei T, Kato S, Ishioka C, Satomi S, Yamada S.
    Int J Radiat Oncol Biol Phys; 2009 Oct 01; 75(2):348-56. PubMed ID: 19735862
    [Abstract] [Full Text] [Related]

  • 18. Concurrent chemoradiotherapy or endoscopic stenting for advanced squamous cell carcinoma of esophagus: a case-control study.
    Wong SK, Chiu PW, Leung SF, Cheung KY, Chan AC, Au-Yeung AC, Griffith JF, Chung SS, Ng EK.
    Ann Surg Oncol; 2008 Feb 01; 15(2):576-82. PubMed ID: 18057993
    [Abstract] [Full Text] [Related]

  • 19. The safety and usefulness of high-dose-rate endoluminal brachytherapy as a boost in the treatment of patients with esophageal cancer with external beam radiation with or without chemotherapy.
    Vuong T, Szego P, David M, Evans M, Parent J, Mayrand S, Corns R, Burtin P, Faria S, Devic S.
    Int J Radiat Oncol Biol Phys; 2005 Nov 01; 63(3):758-64. PubMed ID: 16199311
    [Abstract] [Full Text] [Related]

  • 20. Late toxicity in complete response cases after definitive chemoradiotherapy for esophageal squamous cell carcinoma.
    Kumekawa Y, Kaneko K, Ito H, Kurahashi T, Konishi K, Katagiri A, Yamamoto T, Kuwahara M, Kubota Y, Muramoto T, Mizutani Y, Imawari M.
    J Gastroenterol; 2006 May 01; 41(5):425-32. PubMed ID: 16799883
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.